Turkish Journal of Hematology Volume: 31 - Issue: 4
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Immune Thrombocytopenic Purpura<br />
Thrombocytopenia / Trombositopeni, 32<br />
Long-term survival / Uzun dönem takip, 32<br />
Children / Çocuk, 32<br />
Cerebral infarction / Serebral enfarkt, 184<br />
Idiopathic thrombocytopenic purpura /<br />
İdyopatik trombositopenik purpura, 184<br />
Triple X syndrome / Triple X sendromu, 184<br />
Iron Disorder<br />
Anemia / Anemi, 61<br />
Hepcidin / Hepsidin, 394<br />
Insulin resistance / İnsülin direnci, 61<br />
Iron overload / Demir yükü, 394<br />
Inflammation / İnflamasyon, 61<br />
Obesity / Obezite, 61<br />
Leukocyte<br />
Leukocyte populations / Lökosit popülasyonu, 49<br />
C-reactive protein / C-reaktif protein, 49<br />
Febrile children / Ateşli çocuk, 49<br />
Lymphoma<br />
Lymphoma / Lenfoma, 92,188<br />
Chronic myeloid leukemia / Kronik myeloid lösemi, 92<br />
Secondary malignancy / Sekonder malignite, 92<br />
Adrenal glands / Adrenal bez, 188<br />
Addisonian crisis / Addison krizi, 188<br />
Non-Hodgkin lymphoma / Non-Hodgkin lenfoma, 205,207,403<br />
Lymphoid cells neoplasms / Lenfoid hücreler tümörler, 205<br />
B-Cell neoplasms / B-Hücre tümörleri, 205,207<br />
Pharmacotherapeutics / Farmakoterapötikler, 207<br />
Cytogenetics / Sitogenetik, 290<br />
Non-Hodgkin’s lymphoma / Hodgkin dışı lenfoma, 290,381<br />
Other lymphoproliferative diseases /<br />
Diğer lenfoproliferatif hastalıklar, 290<br />
Other leukemias / Diğer lösemiler, 290<br />
Primary renal lymphoma / Primer renal lenfoma, <strong>31</strong>5<br />
Follicular lymphoma / Foliküler lenfoma, <strong>31</strong>5<br />
Treatment option / Tedavi seçeneği, <strong>31</strong>5<br />
Primary adrenal non-Hodgkin lymphoma /<br />
Primer adrenal non-Hodgkin lenfoma, 332<br />
Central nervous system / Merkezi sinir sistemi, 332<br />
Prognosis / Prognoz, 332<br />
Therapy / Terapi, 332<br />
Vincristine / Vinkristin, 337<br />
Neuropathy / Nöropati, 337<br />
Vocal cord paralysis / Vokal kord paralizi, 337<br />
Paralytic ileus / Paralitik ileus, 337<br />
Chemokines / Kemokinler, 381<br />
Cytokines / Sitokinler, 381<br />
Lymphocytes / Lenfositler, 381<br />
Th2 pathway / Th2 yolağı, 381<br />
Adult T-cell leukemia/lymphoma /<br />
Erişkin T-hücreli lösemi/lenfoma, 424<br />
Mogamulizumab / Mogamulizumab, 424<br />
Hemodialysis / Hemodiyaliz, 424<br />
CCR4 / CCR4, 424<br />
HTLV-1 / HTLV-1, 424<br />
Intravascular large B-cell lymphoma /<br />
İntravasküler büyük B hücreli lenfoma, 403<br />
Prostate / Prostat, 403<br />
Non-germinal center B-cell / Non-germinal merkez B hücre, 403<br />
Multiple Myeloma<br />
Multiple myeloma /<br />
Multiple myeloma, 84,136,2<strong>31</strong>,374,388,428,435,437<br />
LDH / LDH, 84<br />
Prognosis / Prognoz, 84<br />
Renin-angiotensin system / Renin-anjiotensin sistemi, 136<br />
Progenitor cell / Progenitör hücre, 136<br />
CD34+ / CD34+, 136<br />
Drug resistance / İlaç direnci, 2<strong>31</strong><br />
Cell cycle / Hücre döngüsü, 2<strong>31</strong><br />
Apoptosis / Apoptoz, 2<strong>31</strong><br />
HLA-A / HLA-A, 388<br />
HLA-B / HLA-B, 388<br />
HLA-DRB1 / HLA-DRB1, 388<br />
Genetic susceptibility / Genetik yatkınlık, 388<br />
Bone-specific alkaline phosphatase /<br />
Kemik Spesifik Alkalen Fosfataz, 374<br />
Bortezomib / Bortezomib, 374<br />
Thalidomide / Talidomid, 374<br />
Unusual morphology / Olağan dışı morfoloji, 437<br />
Skin / Deri, 435<br />
Necrobiotic / Nekrobiyotik, 435<br />
Xanthogranuloma / Ksantogranüloma, 435<br />
Lymphoproliferative Disorders<br />
Renal transplantation / Böbrek nakli, 79<br />
Post-transplant lymphoproliferative disease/<br />
Posttransplant lenfoproliferatif hastalık, 79<br />
Lymphoma / Lenfoma, 79<br />
Immunosuppression / İmmünsupresyon, 79<br />
Rituximab / Rituksimab, 79<br />
Abnormal karyotype / Anormal karyotip, 79<br />
Mutation<br />
Myeloproliferative disorders / Miyeloproliferatif hastalıklar, 239<br />
Myeloproliferative neoplasm / Myeloproliferatif neoplasm, 239<br />
Essential thrombocythemia / Esansiyel trombositemi, 239<br />
Polycythemia vera / Polisitemia vera, 239<br />
Primary myel<strong>of</strong>ibrosis / Primer myel<strong>of</strong>ibrozis, 239<br />
JAK2V617F mutation / JAK2V617F mutasyonu, 239<br />
Bone marrow histopathology / Kemik iliği histolojisi, 239<br />
Red cell mass / Kırmızı kan hücresi kitlesi, 239<br />
Erythrocyte count / Kırmızı kan hücresi sayısı, 239<br />
Myelodysplasia<br />
Myelodysplasia / Miyelodisplazi, 394<br />
Myeloproliferative Disorders<br />
Myeloproliferative disorders /<br />
Miyeloproliferatif hastalıklar, 121,239<br />
Endothelial cell protein C receptor /<br />
Endotelyal protein C reseptörü, 121
Change language